U.S. markets closed

GlaxoSmithKline plc (GSK)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
37.50+0.23 (+0.62%)
At close: 4:00PM EST
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 12/4/2020
Current
9/30/20206/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
92.22B93.72B101.07B94.00B116.39B106.98B
Enterprise Value 3
124.14B123.86B134.49B125.82B153.96B142.94B
Trailing P/E
10.9811.0115.4716.5419.6319.53
Forward P/E 1
11.6712.6713.8913.0914.8414.35
PEG Ratio (5 yr expected) 1
11.127.598.379.354.863.53
Price/Sales (ttm)
2.042.102.372.282.712.73
Price/Book (mrq)
4.885.406.356.747.6023.96
Enterprise Value/Revenue 3
3.6214.3317.6413.8417.3015.23
Enterprise Value/EBITDA 6
14.2949.3546.8655.7281.4652.76

Trading Information

Stock Price History

Beta (5Y Monthly) 0.33
52-Week Change 3-17.82%
S&P500 52-Week Change 317.96%
52 Week High 348.25
52 Week Low 331.43
50-Day Moving Average 336.53
200-Day Moving Average 339.22

Share Statistics

Avg Vol (3 month) 34.7M
Avg Vol (10 day) 34.81M
Shares Outstanding 52.51B
Float 2.46B
% Held by Insiders 10.01%
% Held by Institutions 111.90%
Shares Short (Nov 12, 2020) 413.8M
Short Ratio (Nov 12, 2020) 42.4
Short % of Float (Nov 12, 2020) 4N/A
Short % of Shares Outstanding (Nov 12, 2020) 40.55%
Shares Short (prior month Oct 14, 2020) 411.34M

Dividends & Splits

Forward Annual Dividend Rate 42.03
Forward Annual Dividend Yield 45.44%
Trailing Annual Dividend Rate 31.06
Trailing Annual Dividend Yield 32.84%
5 Year Average Dividend Yield 45.22
Payout Ratio 462.54%
Dividend Date 3Jan 13, 2021
Ex-Dividend Date 4Nov 11, 2020
Last Split Factor 22:1
Last Split Date 3Nov 11, 1991

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 18.60%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)6.60%
Return on Equity (ttm)36.53%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)-7.90%
Gross Profit (ttm)22.97B
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)0.99
Quarterly Earnings Growth (yoy)-19.80%

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)136.96
Current Ratio (mrq)0.90
Book Value Per Share (mrq)2.41

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A